Invisalign® System with Mandibular Advancement

NCT ID: NCT06651944

Last Updated: 2024-10-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

36 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-02-14

Study Completion Date

2026-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to observe study participants' comfort and fit of their aligners with occlusal blocks, as well as evaluate the engagement of the blocks using the Invisalign® System with mandibular advancement featuring occlusal blocks

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Class II Malocclusion Mandibular Advancement Mandibular Retrognathism Excessive Overjet

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Invisalign® System with Mandibular Advancement

all participants will receive the study device

Group Type EXPERIMENTAL

Invisalign® System with mandibular advancement featuring occlusal blocks

Intervention Type DEVICE

Class II correction using the Invisalign® System with mandibular advancement featuring occlusal blocks

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Invisalign® System with mandibular advancement featuring occlusal blocks

Class II correction using the Invisalign® System with mandibular advancement featuring occlusal blocks

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

• Subject must be eligible for Invisalign treatment with mandibular advancement

Exclusion Criteria

* Subject's dentition not compatible with device or allergy to device materials
* Subject who is pregnant, has active caries, periodontal disease, TMD, root resorption, has HAE (hereditary angioedema), has been diagnosed with epilepsy or any other seizure disorder
Minimum Eligible Age

10 Years

Maximum Eligible Age

16 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Align Technology, Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Astra Orthodontics

Richmond, British Columbia, Canada

Site Status RECRUITING

MacKenzie Orthodontics

Saint John, New Brunswick, Canada

Site Status RECRUITING

Discover Orthodontics

Brampton, Ontario, Canada

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

Canada

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Allison Mossing

Role: CONTACT

4083940304

Karen Srour

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Dr. Sandra Tai, DDS

Role: primary

(604) 270-7828

Dr. Sandra Tai, DDS

Role: backup

Dr. Liliya MacKenzie, DDS

Role: primary

(506) 633-0555

Dr. Liliya MacKenzie, DDS

Role: backup

Dr. Bart Iwasiuk, DDS

Role: primary

(905) 846-7846

Dr. Bart Iwasiuk, DDS

Role: backup

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

A005541

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Primer Aligner Study
NCT02550938 COMPLETED NA